Home » Newsletters » BioWorld Science

BioWorld Science

April 1, 1997

View Archived Issues

Antiinflammatory compounds disclosed by Tsumura

Terumo describes antiallergic agents

Antimicrobial agents disclosed by Maruho

Terumo claims platelet aggregation/thromboxane synthase inhibitors

Takeda reports new carbapenems

New antitumor agents from Daiichi

Wakunaga discloses angiotensin II antagonists

Hypoglycemic/hypolipidemic agents from Sankyo

Shaman commences phase II trials of Provir in AIDS-related diarrhea

Novel 5-HT1A agonist described by Asahi Chemical

IGG's lead compound enters the clinic

Genzyme Transgenics receives further funding for development of transgenic ATIII

Nippon Shinyaku presents novel cerebroprotective agent

Extended treatment with Intron A for hepatitis C cleared by FDA

Sumitomo Metal characterizes new antiallergic/antiinflammatory agent

Ares-Serono and Fournier reach U.S. development and marketing agreement for HRT products

Oxford Molecular/PolyMASC collaborate on development of blood growth factor

Neuroprotective effect of hCNTF in primate model of Huntington's disease

First generic warfarin product cleared by the FDA

Fexofenadine introduced in the U.K.

Ciba Vision launches Ophthalin in U.K.

Syrup formulation of Zofran available in the U.K.

U.K. introduction for intranasal sumatriptan

FS069 MAA accepted for review

Cytogen's Quadramet approved by FDA

ICOS initiates phase I with monoclonal antibody

Anaritide and acute renal failure

Gilead's GS-840 enters phase II for chronic hepatitis B treatment

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...